Results 151 to 160 of about 4,909 (178)

Infrared Thermography Monitoring in Closed Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

2014
Introduction: Intraperitoneal hyperthermia is an essential part of the HIPEC procedure. The selective destruction of malignant cells by hyperthermia in the range of 41 to 43°C has been already demonstrated within adequate experimental and clinical studies. We report the worldwide first use of an[for full text, please go to the a.m. URL]
Jäger, T, Augschöll, C, Dinnewitzer, A, Öfner, D   +3 more
openaire   +1 more source

10289 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

Journal of Minimally Invasive Gynecology, 2023
S Puntambekar, S Inampudi, A Puntambekar, M Patil, M Chitale   +4 more
openaire   +1 more source

Emergencies After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

2016
Since its first description by Spratt in 1980 (Cancer Res 40:253–255, 1980) and further refinement by Sugarbaker, cytoreductive surgery complemented by hyperthermic intraperitoneal chemotherapy (HIPEC) (Ann Surg 221:29–42, 1995) has gained popularity and has entered mainstream care for multiple peritoneal surface malignancies including pseudomyxoma ...
Sinziana Dumitra, Byrne Lee
openaire   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) in gynecologic malignancies

Gynecologic Oncology, 2014
openaire   +1 more source

Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer

European Journal of Surgical Oncology, 2021
Willemien Johanna van Driel, V J Verwaal, I H de Hingh   +2 more
exaly  

Infrared Thermography Monitoring in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Zeitschrift für Gastroenterologie, 2013
T Jäger, A Dinnewitzer, C Augschöll, C Rabl, D Neureiter, D Öfner   +5 more
openaire   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis.

Annali italiani di chirurgia, 2019
Peritoneal carcinomatosis represents the advanced, final stage of peritoneal malignancy, although it is often not accompanied by systemic neoplasia. The development of the pharmaceutical industry in combination with advanced surgery techniques has helped to improve the outcome of these patients, considered for a long time without radical resources ...
Adrian, Bartos, Dana, Bartos, Andrei, Herdean, Bianca, Szabo, Claudia, Militaru, Stoian, Raluca, Mitre, Calin, Cornel, Iancu, Caius, Breazu   +8 more
openaire   +1 more source

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Malignancies

2017
G.E. Bates, P. Kim, C.M. DeRosa, L. Petrukhin, Y. Bressler, R.N. Taub   +5 more
openaire   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials

ESMO Open, 2022
Georgios Markozannes, M Tolia, D Mauri   +2 more
exaly  

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines

Cells, 2020
Hans Rodermond, Juan J García-Vallejo, Roxan Fcpa Helderman   +2 more
exaly